Home
Live Updates
Curis Appoints John A. Hohneker, M.D. To Board Of Directors : vimarsana.com
Curis Appoints John A. Hohneker, M.D. To Board Of Directors
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...
Related Keywords
Evelo Biosciences ,
Burroughs Wellcome ,
Johna Hohneker ,
James Dentzer ,
Genentech ,
Gettysburg College ,
Nasdaq ,
Novartis ,
Curis Inc ,
Therapeutics Inc ,
University Of North Carolina At Chapel Hill ,
Humanigen Inc ,
Biotheryx Inc ,
Health Sciences ,
Global Head Of Development ,
Rutgers School Of Biomedical ,
Drug Administration ,
Aravive Inc ,
Trishula Therapeutics Inc ,
Prnewswire Curis Inc ,
Roche Group ,
Cygnal Therapeutics Inc ,
Global Head ,
Glaxo Wellcome ,
Rutgers School ,
North Carolina ,
Trishula Therapeutics ,
Cygnal Therapeutics ,
Orphan Drug Designation ,
Curis ,
Nc ,
vimarsana.com © 2020. All Rights Reserved.